Aim High Investment Group LLC v. Spectrum Laboratories, LLC ( 2024 )

1 UNITED STATES DISTRICT COURT 2 DISTRICT OF NEVADA 3 4 AIM HIGH INVESTMENT GROUP, LLC, ) ) Case No.: 2:22-cv-00158-GMN-DJA 5 Plaintiff, ) 6 vs. ) ) 7 SPECTRUM LABORATORIES, LLC, ) ORDER DENYING ) AIM HIGH’S OBJECTION 8 Defendant. ) ) 9 ) 10 SPECTRUM LABORATORIES, LLC, ) ) 11 Counter-Claimant, ) vs. ) 12 ) 13 AIM HIGH INVESTMENT GROUP, LLC, ) ) 14 Counter-Defendant. ) ) 15 16 Pending before the Court is Plaintiff and Counter-Defendant Aim High Investment 17 Group’s (“Aim High’s”) Objection/Appeal, (ECF No. 91), to the Magistrate Judge’s Orders, 18 (ECF Nos. 86, 89), denying Aim High’s Motion to Compel Discovery (ECF No. 45). 19 Defendant and Counter-Claimant Spectrum Laboratories (“Spectrum”) filed a Response, (ECF 20 No. 94), to the Objection. 21 Because Aim High fails to establish that the Magistrate Judge’s Order was clearly 22 erroneous or contrary to law, the Court DENIES Aim High’s Objection.1 23 /// 24 25 1 ECF No. 86 is the Magistrate Judge’s sealed order, and ECF No. 89 is the redacted version. For simplicity, this Order will refer to them as one order, in the singular. 1 I. BACKGROUND 2 This action arises from a patent infringement dispute based on Spectrum’s patented 3 synthetic urine formulas. (See generally Compl., ECF No. 1). The patents center on a formula 4 containing biocides added to minimize bacteria growth in the mixture, thus preserving the shelf 5 life of the synthetic urine. (Id. ¶ 2). Before litigation began, Spectrum sent a letter to Aim High 6 alleging that the XStream product infringed two of its Patents. (Id. ¶ 11). In response, Aim 7 High denied the allegation and requested lab tests demonstrating infringement. 8 (Correspondence, Exs. A-C to Resp. to Mot. Compel, ECF Nos. 51-1, 51-2, 51-3). Spectrum 9 provided a redacted report from S&N Laboratories, stating that the report was disclosed 10 “without any waiver of privilege or work-product.” (Confidential Letter, Ex. D to Resp. Mot. 11 Compel, ECF No. 51-4). Aim High challenged the authenticity of the report, so Spectrum sent 12 Aim High a report from a second lab, Element Laboratories. (Letter and Element Report, Ex. 2 13 to Mot Compel, ECF No. 45-3). Aim High reviewed the correspondence and lab reports, and 14 then brought a claim for declaratory judgment that its XStream product does not infringe on 15 Spectrum’s patents. (Compl. ¶ 1). Spectrum counter-claimed for injunctive relief and damages, 16 alleging that the XStream product did infringe. (Counterclaim, ECF No. 7). 17 A. Related Litigation in California 18 In the United States District Court for the Central District of California, Aim High 19 issued subpoenas to S&N and Element. (Subpoenas, Exs. 9-10 to Resp. to Mot. Compel, ECF 20 No. 51-9, 51-10). The subpoenas requested undisclosed documents and communications 21 relating to any chemical testing of XStream or testing of third-party products done for the 22 purpose of detecting a biocide. (Id.). Both labs objected on work-product grounds as to 23 XStream, and work-product and irrelevance as to the third-party products. (Opp. to CA Mot. 24 Compel, Ex. 10 to Mot. Compel, ECF No. 45-11). 25 /// 1 Aim High moved to compel the documents. (CA Mot. Compel, Ex. 9 to Mot. Compel, 2 ECF No. 45-10). Aim High’s Motion argued the labs should be ordered to comply with the 3 subpoenas because Spectrum produced the reports in pre-litigation correspondence and 4 “expressly referenced the Element lab report as a document Spectrum was relying on to support 5 its claims.” (Id. 3:11–19). Aim High also pointed out that Spectrum listed the Element report in 6 its initial disclosures. (Id. 5:17–18). 7 Spectrum, S&N, and Element opposed the motion to compel because (1) an expert does 8 not waive work-product for undisclosed documents unless and until they are designated as the 9 testifying expert and produce a report, and (2) the testing of third-parties was irrelevant. (Resp. 10 at 4, ECF No. 94) (Opp. to CA Mot. Compel at 4–5, Ex. 10 to Mot. Compel). The California 11 Magistrate Judge ruled in Spectrum’s favor. (See generally Order, Ex. 12 to Mot. Compel, ECF 12 No. 45-13). The Magistrate Judge determined that Federal Rule of Civil Procedure 13 26(b)(4)(D), which prohibits a party from discovering facts known or opinions held by a non- 14 testifying expert retained in anticipation of litigation or preparation for trial, protected the labs 15 from compliance with Aim High’s subpoena. (Id. at 5–6). The protection was not waived 16 simply because Spectrum provided the reports to Aim High during pre-litigation discussions. 17 (Id.). 18 Aim High objected to the portion of the California Judge’s Denial of compelled 19 responses relating to Element’s testing of XStream. (CA Obj. at 2, Ex. 13 to Mot. Compel, ECF 20 No 45-14). Aim High argued that Spectrum’s citing of the Element test in its counterclaim 21 constituted a waiver of the work-product privilege and that the Magistrate Judge overlooked 22 Spectrum’s initial disclosures and counterclaim citations to Element’s lab test. (Id. at 2, 8). As 23 of the date of this Order, the District Judge in the Central District of California has not yet ruled 24 on Aim High’s objection. 25 /// 1 B. Magistrate Judge Albregts’ Denial of Aim High’s Motion to Compel 2 Aim High then filed another motion to compel Spectrum to respond to Aim High’s 3 Interrogatories Nos. 2–6 and Requests for Production Nos. 2–6 in this case. (Mot. Compel at 2, 4 ECF No. 45). Magistrate Judge Albregts determined that Aim High’s questions sought 5 “information like that which Aim High sought from Element and S&N.” (MJ Order 5:1–6:1, 6 ECF No. 89). In its NV Motion to Compel, Aim High made many similar arguments, such as 7 that Spectrum waived the work-product privilege by citing the Element lab test in its 8 counterclaim, and that Spectrum provided false information to the California Magistrate Judge 9 by stating that it only used the reports for settlement discussions and not to prove infringement. 10 (Id. 6:5–12). 11 Magistrate Judge Albregts denied Aim High’s Motion to Compel as “premature” 12 because of Aim High’s pending objection before the United States District Court for the 13 Central District of California, citing R.R. Street & Co. Inc. v. Transport Ins. Co., 656 F.3d 966 14 (9th Cir. 2011). (Id. 2:1–4). In R.R. Street, the Ninth Circuit explained that “courts usually 15 avoid duplicative litigation when similar cases are pending in two different federal courts,” and 16 that “[p]iecemeal litigation occurs when different tribunals consider the same issue, thereby 17 duplicating efforts and possibly reaching different results.” 656 F.3d at 974–75, 979. 18 The Magistrate Judge explained, because Aim High’s discovery requests to Spectrum 19 raise similar issues to the issues currently before the California District Court, the California 20 decision would “alter the scope of Aim High’s requests.” (MJ Order 2:14). He also noted that 21 Aim High made the same arguments in its NV Motion to Compel that it made in its objections 22 to the California Magistrate Judge’s Order. (Id. 7:11–15). “And if this Court were to find that 23 Spectrum must respond to Aim High’s discovery requests, but the California court were to find 24 that S&N and Element need not provide that same information, it could create a problematic 25 contradiction.” (Id. 7:12–15). Aim High now appeals this Order. (Obj., ECF No. 91). 1 II. LEGAL STANDARD 2 When reviewing the order of a magistrate judge, the order should be set aside only if the 3 order is clearly erroneous or contrary to law. Fed. R. Civ. P. 72(a); LR IB 3-1(a); 28 U.S.C. 4 § 636(b)(1)(A); Laxalt v. McClatchy, 602 F. Supp. 214, 216 (D. Nev. 1985). A magistrate 5 judge’s order is “clearly erroneous” if the court has “a definite and firm conviction that a 6 mistake has been committed.” See United States v. U.S. Gypsum Co., 333 U.S. 364, 395 (1948). 7 “An order is contrary to law when it fails to apply or misapplies relevant statutes, case law or 8 rules of procedure.” UnitedHealth Grp., Inc. v. United Healthcare, Inc., No. 2:14-cv-00224- 9 RCJ, 2014 WL 4635882, at *1 (D. Nev. Sept. 16, 2014) (citation omitted). When reviewing the 10 order, however, the magistrate judge “is afforded broad discretion, which will be overruled 11 only if abused.” Columbia Pictures, Inc. v. Bunnell, 245 F.R.D. 443, 446 (C.D. Cal. 2007) 12 (citation omitted). The district judge “may not simply substitute its judgment” for that of the 13 magistrate judge. Grimes v. City and Cnty. of San Francisco, 951 F.2d 236, 241 (9th Cir. 14 1991). 15 III. DISCUSSION 16 The Court finds that Aim High fails to establish that the Magistrate Judge’s Order was 17 clearly erroneous or contrary to law. Aim High’s primary contention is that the underlying 18 Order is clearly erroneous because it is based on an alleged overlap with a ruling derived from 19 incorrect facts and false statements. (Obj. 1:13–16). Aim High claims that Spectrum falsely 20 asserted to the California Magistrate Judge that it was not relying on the lab reports to support 21 its counterclaims and infringement contentions. (Id. 3:15–19). Thus, Aim High contends, the 22 California Magistrate Judge only evaluated the reports as being produced during “prelitigation 23 discussions,” and did not consider Spectrum’s reliance on the reports in its counterclaims. (Id. 24 5:19–6:2). Spectrum argues that its alleged “lie” was taken out of context, because it was only 25 explaining that it had not yet chosen, at that stage of litigation, which expert reports and 1 chemical testing would be used to offensively prove infringement. (Resp. at 10–11, ECF No. 2 94). 3 But regardless of what Spectrum represented to the California Magistrate Judge, Aim 4 High’s California Objection argues that because Spectrum cited the lab results in its 5 counterclaim, it waived the work-product privilege. And Aim High’s California Motion to 6 Compel explained that Spectrum referenced the lab reports as a document it was relying on to 7 support its claims. (See CA Mot. Compel 3:11–19, Ex. 9 to Mot. Compel). So, the Central 8 District of California will resolve the issue regarding the way in which Spectrum will use the 9 reports and whether that use impacts waiver. As Magistrate Judge Albregts pointed out, Aim 10 High made the same arguments in its NV Motion to Compel that it made in its objections to the 11 California Magistrate Judge’s Order. (MJ Order 7:11–15). Thus, it was not clearly erroneous 12 for Magistrate Judge Albregts to find a sufficient overlap with ongoing proceedings in the 13 Central District of California. 14 Aim High further argues that the Magistrate Judge clearly erred by failing to grant 15 “relief on discovery requests that do not overlap or only partially overlap with the limited third 16 party requests that are the subject of the California subpoena proceeding.” (Obj. 16:3–13). Aim 17 High claims the Magistrate Judge should have allowed certain requests for production and 18 interrogatories relating to information that only Spectrum would have in its control, as well as 19 information concerning all third-party testing of its XStream Product and biocides. (Id. 16:15– 20 18:22). But almost all, if not all, of Aim High’s requests might involve answers relating to the 21 S&N and Element lab reports. For that reason, Aim High’s disagreement with the Magistrate 22 Judge’s decision is not sufficient to find the Order clearly erroneous or contrary to law. 23 Aim High’s additional argument, that “the discovery requests to Spectrum are not 24 duplicative of the discovery requests to third parties because party discovery obligations differ 25 from non-party discovery obligations,” is similarly insufficient. (See id. 19:20–23). Though 1 Plaintiff is generally correct that discovery obligations between parties and non-parties differ, 2 the argument in unpersuasive in this case where Plaintiff’s subpoena to third parties and 3 potential waiver is currently being decided by a different federal court. Plaintiff’s cited cases 4 arise from distinguishable facts, and neither case involves the issue of a third-party subpoena in 5 another court. See Linksmart Wireless Tech., LLC v. Caesars Ent. Corp., No. 2:18-cv-00862- 6 MMD-NJK, 2020 WL 4431498, at *3 (D. Nev. July 31, 2020) (holding that it is not 7 unreasonably cumulative or duplicative for the defendants to request documents from a third- 8 party, even though plaintiff had already subpoenaed the same documents); Photography By 9 Frank Diaz LLC v. Friends of David Schweikert, No. CV-22-01170-PHX-JAT, 2023 WL 10 3078664, at *4 (D. Ariz. Apr. 25, 2023) (determining discovery was not cumulative or 11 duplicative when defendants were likely to have more complete responses as to their own 12 correspondence than non-parties, and when there was no guarantee the third party retained all 13 message communications). 14 Aim High also attempts to distinguish this case from R.R. Street because the Ninth 15 Circuit case involved two separate complaints; here, the California court proceeding was a 16 subpoenas duces tecum served on Element and S&N due to their XStream product testing. 17 (Obj. 19:9–14). Aim High fails to cite relevant case law demonstrating that this distinction is 18 an important one. 19 The Court does not have a definite and firm conviction that Judge Albregts committed a 20 mistake by denying Aim High’s Motion to Compel without prejudice because of the relevant 21 and ongoing discovery proceeding in California. Magistrate Judge Albregts is to be afforded 22 broad discretion, and Aim High’s general disagreement with this Order does not mean that this 23 Court can, or should, substitute its own judgment. Accordingly, the Court DENIES Aim 24 High’s Objection. 25 1 IV. CONCLUSION 2 IT IS HEREBY ORDERED that Aim High’s Objection/Appeal, (ECF No. 91), is 3 DENIED. 4 DATED this __1_4__ day of February, 2024. 5 6 ___________________________________ Gloria M. Navarro, District Judge 7 UNITED STATES DISTRICT COURT 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25